What adjuvant chemotherapy regimen is most appropriate for a patient with local recurrence several years after surgery and ddAC-T for localized breast cancer?
The CALOR study showed a benefit of adjuvant chemotherapy for local recurrence but the regimens given were "physicians choice".
Answer from: Medical Oncologist at Academic Institution
In this situation, it is preferable to use a chemotherapy regimen that has been shown to be effective in the adjuvant setting. For a patient who has already received ddAC-T, my choice would be TC (docetaxel/cyclophosphamide), or even CMF. The role of chemotherapy for locoregional recurrence is sti...
Answer from: Medical Oncologist at Academic Institution
I agree with @Debu Tripathy. The CALOR study supports "physicians choice" chemotherapy in the setting of a local recurrence but unfortunately it doesn't guide specific chemotherapy regimens. My specific chemotherapy recommendations are often influenced by the disease free interval, histology, compli...